RLF-100 Expanded Access Program At Houston Methodist Hospital 9-Fold Increased Probability of Survival from Critical COVID-19

Patients with critical COVID-19 and respiratory failure treated with RLF-100™ (aviptadil) have a 9-fold increased probability of survival and recovery from respiratory failure than those patients only on the standard of care, reports Relief Therapeutics Holding AG...

Pin It on Pinterest